INTEGRA LIFESCIENCES HOLDINGS CORP Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent of $1.31 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-26.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent · last filed 2013-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for fiscal 2012 was $1.31M.
- INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for fiscal 2011 was -$861.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive (income) loss, defined benefit plan, before tax, after reclassification adjustment, attributable to parent for fiscal 2010 was -$329.00K.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Tax, after Reclassification Adjustment, Attributable to Parent 12 month |
|---|---|
| 2012-12-31 | $1.31M 10-K · filed 2013-02-26 |
| 2011-12-31 | -$861.00K 10-K · filed 2013-02-26 |
| 2010-12-31 | -$329.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |